Skip to main navigation Skip to search Skip to main content

A phase 2B long-term, randomized, open-label, safety and tolerability trial comparing [S,S]-Reboxetine (PNU-165442G) with routine care in patients with chronic painful diabetic peripheral neuropathy (DPN)

  • Weinstock, Ruth (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date06/2/06 → 06/30/09

Funding

  • Pfizer Incorporated: $6,296.50